Cargando…

Benchmarking tocilizumab use for giant cell arteritis

Detalles Bibliográficos
Autores principales: Conway, Richard, Putman, Michael S, Mackie, Sarah L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115674/
https://www.ncbi.nlm.nih.gov/pubmed/35601271
http://dx.doi.org/10.1093/rap/rkac037
_version_ 1784709968823320576
author Conway, Richard
Putman, Michael S
Mackie, Sarah L
author_facet Conway, Richard
Putman, Michael S
Mackie, Sarah L
author_sort Conway, Richard
collection PubMed
description
format Online
Article
Text
id pubmed-9115674
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91156742022-05-19 Benchmarking tocilizumab use for giant cell arteritis Conway, Richard Putman, Michael S Mackie, Sarah L Rheumatol Adv Pract Editorial Oxford University Press 2022-05-09 /pmc/articles/PMC9115674/ /pubmed/35601271 http://dx.doi.org/10.1093/rap/rkac037 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Conway, Richard
Putman, Michael S
Mackie, Sarah L
Benchmarking tocilizumab use for giant cell arteritis
title Benchmarking tocilizumab use for giant cell arteritis
title_full Benchmarking tocilizumab use for giant cell arteritis
title_fullStr Benchmarking tocilizumab use for giant cell arteritis
title_full_unstemmed Benchmarking tocilizumab use for giant cell arteritis
title_short Benchmarking tocilizumab use for giant cell arteritis
title_sort benchmarking tocilizumab use for giant cell arteritis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115674/
https://www.ncbi.nlm.nih.gov/pubmed/35601271
http://dx.doi.org/10.1093/rap/rkac037
work_keys_str_mv AT conwayrichard benchmarkingtocilizumabuseforgiantcellarteritis
AT putmanmichaels benchmarkingtocilizumabuseforgiantcellarteritis
AT mackiesarahl benchmarkingtocilizumabuseforgiantcellarteritis